Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-03 10:53 am Purchase | 2026-03-30 | 13G | LANTERN PHARMA INC LTRN | Thomas A. Satterfield, Jr. | 570,000 5.100% | 570,000![]() (New Position) | Filing History |
| 2026-02-23 4:37 pm Sale | 2026-02-20 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 960,026 8.580% | -115,926![]() (-10.77%) | Filing History |
| 2025-06-13 7:43 pm Sale | 2025-06-12 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 1,075,952 9.980% | -187,850![]() (-14.86%) | Filing History |
| 2024-03-01 4:10 pm Sale | 2024-02-28 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 1,263,802 11.800% | -202,889![]() (-13.83%) | Filing History |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | LANTERN PHARMA INC LTRN | ProPhase Labs Inc. PRPH | 631,195 5.800% | -278,805![]() (-30.64%) | Filing History |
| 2023-12-01 06:02 am Sale | 2023-11-29 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 1,466,691 13.600% | -508,150![]() (-25.73%) | Filing History |
| 2022-11-21 4:15 pm Purchase | 2022-11-08 | 13G | LANTERN PHARMA INC LTRN | ProPhase Labs Inc. PRPH | 910,000 8.400% | 910,000![]() (New Position) | Filing History |
| 2022-03-22 4:15 pm Purchase | 2022-03-17 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 1,974,841 18.100% | 5,855![]() (+0.30%) | Filing History |
| 2022-01-11 10:31 am Sale | 2021-12-31 | 13G | LANTERN PHARMA INC LTRN | Empery Asset Management LP | 0 0.000% | -700,000![]() (Position Closed) | Filing History |

